These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30507421)

  • 21. Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program.
    Calhoun EA; Bennett CL
    Oncology (Williston Park); 2003 Jan; 17(1):109-14; discussion 119-21. PubMed ID: 12599935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the cost of cancer care in the United States: a work very much in progress.
    Lipscomb J
    J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer incidence trends in India.
    Badwe RA; Dikshit R; Laversanne M; Bray F
    Jpn J Clin Oncol; 2014 May; 44(5):401-7. PubMed ID: 24755545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costing of a State-Wide Population Based Cancer Awareness and Early Detection Campaign in a 2.67 Million Population of Punjab State in Northern India.
    Thakur J; Prinja S; Jeet G; Bhatnagar N
    Asian Pac J Cancer Prev; 2016; 17(2):791-7. PubMed ID: 26925682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer economics: on variations in the costs of treating cancer.
    Chirikos TN
    Cancer Control; 2002; 9(1):59-66. PubMed ID: 11907467
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing cancer care, outcomes, and costs across health systems: charting the course.
    Lipscomb J; Yabroff KR; Hornbrook MC; Gigli A; Francisci S; Krahn M; Gatta G; Trama A; Ritzwoller DP; Durand-Zaleski I; Salloum R; Chawla N; Angiolini C; Crocetti E; Giusti F; Guzzinati S; Mezzetti M; Miccinesi G; Mariotto A
    J Natl Cancer Inst Monogr; 2013; 2013(46):124-30. PubMed ID: 23962516
    [No Abstract]   [Full Text] [Related]  

  • 27. The prevention and treatment (and cost) of cancer.
    Martens E
    ACS Chem Biol; 2007 Oct; 2(10):637-9. PubMed ID: 18041808
    [No Abstract]   [Full Text] [Related]  

  • 28. Reported cancer spending in relation to population characteristics, disease burden and service activity for primary care trusts in South East England.
    Okello C; Møller H; Davies EA
    J Public Health (Oxf); 2011 Sep; 33(3):445-52. PubMed ID: 21051461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value and cancer care: toward an equitable future.
    Schnipper LE; Meropol NJ; Brock DW
    Clin Cancer Res; 2010 Dec; 16(24):6004-8. PubMed ID: 21169254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea.
    Bae JM
    J Prev Med Public Health; 2017 Jul; 50(4):217-227. PubMed ID: 28768400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
    Schilsky RL
    J Clin Oncol; 2009 Aug; 27(23):3725-30. PubMed ID: 19581526
    [No Abstract]   [Full Text] [Related]  

  • 32. The growing burden of cancer in India: epidemiology and social context.
    Mallath MK; Taylor DG; Badwe RA; Rath GK; Shanta V; Pramesh CS; Digumarti R; Sebastian P; Borthakur BB; Kalwar A; Kapoor S; Kumar S; Gill JL; Kuriakose MA; Malhotra H; Sharma SC; Shukla S; Viswanath L; Chacko RT; Pautu JL; Reddy KS; Sharma KS; Purushotham AD; Sullivan R
    Lancet Oncol; 2014 May; 15(6):e205-12. PubMed ID: 24731885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ought cancer treatments to be immune from socio-economic evaluation? An epilogue.
    Culyer AJ; Jönsson B
    Eur J Cancer; 1993; 29A Suppl 7():S31-2. PubMed ID: 8312061
    [No Abstract]   [Full Text] [Related]  

  • 34. Costs of cancer care in children and adolescents in Ontario, Canada.
    de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28500732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Cost of Illness of Three Major Diseases in Japan.
    Matsumoto K; Hanaoka S; Wu Y; Hasegawa T
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1934-1940. PubMed ID: 28712721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment costs pose major financial stress for patients.
    Printz C
    Cancer; 2019 Feb; 125(4):495. PubMed ID: 30698837
    [No Abstract]   [Full Text] [Related]  

  • 38. [Assessing the economic impact of cancer in Chile: a direct and indirect cost measurement based on 2009 registries].
    Cid C; Herrera C; Rodríguez R; Bastías G; Jiménez J
    Medwave; 2016 Aug; 16(7):e6509. PubMed ID: 27532152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Growing Burden Of Noncommunicable Diseases.
    Weil AR
    Health Aff (Millwood); 2015 Sep; 34(9):1439. PubMed ID: 26355043
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving cancer care in India: prospects and challenges.
    Pal SK; Mittal B
    Asian Pac J Cancer Prev; 2004; 5(2):226-8. PubMed ID: 15244530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.